• Ian Spatz

    Senior Advisor
    Healthcare Industry
    ispatz@manatt.com
    Download Contact (.vcf)

    Los Angeles
    Direct: 310.312.4339
    General: 310.312.4000
    Fax: 310.312.4224

    Education

    New York University School of Law, J.D.

     

    Princeton University, Woodrow Wilson School of Public and International Affairs, M.P.P.

     

    Brandeis University, B.A.

    Bar Admissions
    Washington, D.C.
    • Profile
    • Representative Matters
    • Honors & Awards
    • Publications
    • Memberships & Activities
    • Speaking Engagements

    Profile

    Ian Spatz is a Senior Advisor in the national healthcare practice of Manatt, Phelps & Phillips, LLP and Manatt Health Solutions.  Mr. Spatz provides highly experienced insights into ongoing health reform efforts, helps develop public and private strategies and guidance on a broad array of issues affecting healthcare providers and insurers, pharmaceutical companies, the consuming public and U.S. healthcare initiatives generally, as well as the development and implementation of communication and advocacy efforts at the federal and state levels. Among his areas of expertise are national healthcare policies and programs; pharmaceutical pricing, including Medicare and Medicaid; intellectual property protection; and policies related to the U.S. Food and Drug Administration's regulation of the research, approval, manufacturing and marketing of medicines.

    Mr. Spatz is also the founder and principal of the policy consulting firm Rock Creek Policy Group, LLP.  Before founding Rock Creek Policy Group, Mr. Spatz served for 15 years in increasingly responsible positions with Merck & Co., Inc., one of the world's leading research-based pharmaceutical and vaccine companies.  As Merck's Vice President for Global Health Policy, he directed U.S. public policy and related public affairs activities and represented the company before Congress, the Administration, and to the media.  He also directed grassroots, employee communications and political action programs.  

    While at Merck, Mr. Spatz led the successful five-year campaign that helped to develop and gain enactment of the Medicare prescription drug benefit, providing millions of American elderly and persons with disabilities with drug insurance for the first time.  He promoted legislation to create the highly successful program of market exclusivity incentives for research on the pediatric uses of medicines and guided company efforts that resulted in resolution of international trade dispute on the licensing of medicines in the developing world.

    Before joining Merck, Mr. Spatz served as Legislative Director for U.S. Senator Frank Lautenberg (D-NJ).  In that role, he directed the Senator's legislative staff including developing and supervising the implementation of legislative strategies, proposal drafting and floor action.  During his tenure, he coordinated the successful development and passage of two transportation appropriations bills.  He began his career in the nonprofit sector where he led the public policy and government affairs activities of the National Trust for Historic Preservation, the nation's leading heritage conservation organization. While with the National Trust, he conceived the highly successful Eleven Most Endangered Historic Places list that has served as a model public relations tool for many conservation organizations.  He advocated successfully for the creation of the transportation enhancements funding in the Intermodal Surface Transportation Act (ISTEA) that has resulted in more than $8 billion in spending on conservation projects. 

    Representative Matters

    Honors & Awards

    Publications

    Coauthor, “Five Megatrends Driving the Seismic Shift in Healthcare: How Should Pharma Respond to Succeed in a Transformed Market?” Manatt Health Solutions, July 2014.

    Author, “Medicare Part D Proposed Rule: Where Did Things Go Wrong?” Health Affairs blog, March 6, 2014.

    Coauthor, “Specialty Pharmaceuticals,” Health Affairs, November 25, 2013.

    Coauthor, "Sequestration and Medicare: The Two Percent Solution?" BNA's Medicare Report, September 16, 2011.

    Coauthor, "The Proposed ACO Program: Issues for the Life Sciences Industry," BNA's Life Sciences Law & Industry Report, May 6, 2011.

    Coauthor, “Affordable Care Act Provisions in the 2011 Medicare Physician Fee Rule,” BNA’s Medicare Report, July 23, 2010.

    Memberships & Activities

    Admitted to practice in Washington, D.C.

    Speaking Engagements